Experimental group:naotai Capsule

2 trials

Sponsors

Hu'nan University of Chinese Medicine

Conditions

Hypertension-induced cerebral small vessel disease

Early Phase 1

Naotai Fang for prevention and treatment of hypertensive cerebral small vessel disease: randomized, double-blind, placebo-controlled, multi-center clinical trial protocol

Active, not recruitingITMCTR1900002466

Hu'nan University of Chinese MedicineHypertension-induced cerebral small vessel disease

Start: 2019-08-01Updated: 2023-02-20

Naotai Fang for prevention and treatment of hypertensive cerebral small vessel disease: randomized, double-blind, placebo-controlled, multi-center clinical trial protocol

Active, not recruitingChiCTR1900024524

Hu'nan University of Chinese MedicineHypertension-induced cerebral small vessel disease

Start: 2019-08-01Updated: 2019-07-15

Related Papers

Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial

Frontiers in Pharmacology2023-01-067 citations